• CRENEZUMAB chembl:CHEMBL1743004

    Alternate Names:

    RG-7412
    MABT5102A
    RG7412
    CRENEZUMAB

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications for treatment of Alzheimer's disease
    (0 More Sources)

    Publications:

  • Interaction Score: 5.98

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Novel Target
    Trial Name MABT5102A
    Mechanism of Interaction Beta amyloid A4 protein other

    PMIDs:
    None found